As Per the Report, the Size of the Asia Pacific Intra-Abdominal Pressure Measurement Devices (IPMD) Market is valued at USD 10.79 million in 2024 and is expected to reach USD 24.48 Million by 2029, growing at a CAGR of 17.8% during the forecast period 2023 to 2028.
There are many advances in hospital settings, which enable the development of a convenient and straightforward procedure for measuring intra-abdominal pressure. It can be easily performed even in a peripheral hospital and tested in clinical trials. The intra-abdominal pressure measurement devices use indirect pressure measurement with the bladder along with the intra-abdominal and extraperitoneal organs.
The prevalence of hospital-acquired infections (HAIs) increases in the most seriously ill patients and is associated with a significant increase in morbidity and mortality. In the presence of tight abdominal distension, abdominal compartment syndrome (ACS) and intra-abdominal hypertension (IAH) develop. According to the Australian Health Department, the incidence of HAIs can range from 1.5% to 50.5% of intensive care patients. According to a report published in the Critical Care Medicine Journal, intra-abdominal hypertension occurs in 82% of patients admitted to intensive care.
Increased intra-abdominal pressure (IAP) causes tissue hypoperfusion, leading to multi-organ dysfunction syndromes and affecting the functioning of almost all other organ systems. ACS is life-threatening, with a death rate of 40 to 100%. Monitoring intra-abdominal pressure is an essential measurement tool in diagnosing, preventing and treating IAH and ACS. Monitoring of IAP is of great importance in improving the survival of ICU patients with ACS.
The insertion of equipment such as catheters and pressure transducers into the abdominal cavity, stomach, and rectum results in higher costs and discomfort for patients, which may be a limiting factor for the growth of the APAC IPMD. Complicated surgical techniques can lead to elevated risk for adhesions, which can provide false results may pose a threat to the APAC IPMD market growth in the years to come.
India
Geographically, Chinese IPMD market is estimated to have a dominant market share in the APAC intra-abdominal pressure measuring devices (IPMD) over the projected period. This regional market growth can be linked to the untapped market demand, increased intra-abdominal hypertension, other associated conditions, and developed healthcare facilities. In addition, a higher rate of HAIs will drive this regional market. According to sciencedata.org, a single-day HAIs point prevalence study was conducted in a tertiary care hospital located in China. The overall prevalence rate observed for HAIs was reported to be over 3.50% among 2434 inpatients being surveyed.
Several key players are increasing the pressure on their competitors in the Western market to lower the prices of products and components by offering relatively cheaper products. However, this price pressure from suppliers offering features from Chinese players may affect the quality of the products in the long run, which may hamper the growth during the analysis period.
In the Indian IPMD market, the market will be driven by the growing rate of HAI and improving healthcare facilities coupled with a large patient base. The overall prevalence of HAI recorded in India was about 3.77%. Identified Surgical Intensive Care Unit (25.55%), medical ICU (20.52%), burns ward (20.11%), and pediatric ward (12.77%) were to have a significant association with HAIs rate in the region.
Top Companies leading the Asia Pacific Intra-Abdominal Pressure Measurement Devices (IPMD) Market Profiled in the Report are C. R. Bard, Inc., ConvaTec Group PLC, Holtech Medical, Centurion Medical Products, Biometrix Ltd.(Degania Silicone, Ltd.), Stryker Corporation. Other players in the market include Spiegelberg GmbH, Nutrimedics S.A, Potrero Medical Inc and Gaeltec.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region